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Abstract  
Acute kidney injury (AKI) is a common complication following cardiac surgery performed on 
cardiopulmonary bypass (CPB) and has important implications for prognosis. The aetiology 
of cardiac surgery-associated AKI is complex, but renal hypoxia, particularly in the medulla, 
is thought to play at least some role. There is strong evidence from studies in experimental 
animals, clinical observations and computational models, that medullary ischaemia and 
hypoxia occurs during CPB. There are no validated methods to monitor or improve renal 
oxygenation during CPB, and thus possibly decrease the risk of AKI. Attempts to reduce the 
incidence of AKI by early transfusion to ameliorate intra-operative anaemia, refinement of 
protocols for cooling and rewarming on bypass, optimisation of pump flow and arterial 
pressure, or the use of pulsatile flow, have not been successful to date. This may in part 
reflect the complexity of renal oxygenation, which may limit the effectiveness of individual 
interventions. We propose a multidisciplinary pathway for translation comprising three 
components. Firstly, large-animal models of CPB to continuously monitor both whole kidney 
and regional kidney perfusion and oxygenation. Secondly, computational models to obtain 
information that can be used to interpret the data and develop rational interventions. 
Thirdly, clinically feasible non-invasive methods to continuously monitor renal oxygenation 
in the operating theatre and to identify patients at risk of AKI. In this review we outline the 
recent progress on each of these fronts.  
    
Keywords: Acute kidney injury, renal hypoxia, renal ischaemia, renal medulla.  
 
Introduction 
The development of cardiopulmonary bypass (CPB), to allow cardiothoracic surgeons to 
operate on a motionless and bloodless field while the patient’s cardiovascular system is 
sustained by a heart-lung machine, was one of the greatest medical breakthroughs of the 
20th century. It makes the ~2 million coronary artery bypass graft procedures or valve 
replacement or repair procedures performed annually worldwide possible.1 However, one 
of the major risks associated with on-pump cardiac surgery is acute kidney injury (AKI). 
Globally the incidence of AKI after cardiac surgery has been estimated at 22.3%, although it 
does vary according to the diagnostic criteria used.1 When AKI is severe enough to require 
renal replacement therapy, as occurs in 1-2% of patients after CPB, mortality exceeds 35%.2 
But even mild AKI after CPB is associated with a more than 4-fold greater risk of in-hospital 
death and greater risk of extended hospitalisation.3 Furthermore, there is now very strong 
evidence that even short or mild episodes of AKI are independently associated with a greatly 
increased risk of chronic kidney disease (CKD).4, 5 
Our efforts to prevent AKI associated with cardiac surgery are hampered by three major 
challenges. The first challenge is that we have little ability to predict which patients will 
develop AKI after cardiac surgery. Pre-operative risk scoring systems are available, but these 
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intra-operatively, prior to development of kidney injury. Urinary and plasma biomarkers 
have been developed that allow early detection of AKI.8 However, at best these can predict 
AKI on arrival at the intensive care unit (i.e. after the operation),9 and even then their 
predictive efficacy is rather low.10, 11 The third challenge is that we have no effective 
interventions, either during the surgical procedure itself or once AKI has been diagnosed.12-
16 This suggests that continuous assessment of the kidney during surgery would be 
advantageous, as this is a promising time for an effective intervention. 
There are also significant impediments to the development of interventions to prevent or 
ameliorate AKI associated with cardiac surgery. Patients undergoing cardiac surgery are, for 
the most part, critically ill. Therefore, the implementation of interventions with 
questionable efficacy is problematic. Cardiac surgery and CPB are also technically 
challenging to model in animals.17 Thus, there are roadblocks in our ability to test new 
interventions both in pre-clinical and clinical settings. Another consequence of these 
impediments is that our understanding of the pathophysiology of cardiac surgery-associated 
AKI is poor, and so a rational basis for intervention is commensurately limited.  
In this article we review the evidence that renal tissue hypoxia, particularly in the medulla is 
a likely important driver of AKI, including in the setting of cardiac surgery. We then consider 
how renal hypoxia could be targeted, both as a way of monitoring risk of AKI and as a 
therapeutic or management target.  
 
Renal Oxygenation 
The oxygenation of all bodily tissues is determined by the balance between oxygen delivery 
and oxygen consumption. But in the kidney, this apparent simplicity is belied by the 
complexity of the determinants of oxygen delivery and oxygen consumption, particularly in 
the renal medulla.18 In terms of oxygen delivery, we must consider the fact that the renal 
circulation is arranged in parallel with the non-renal circulations, that the medullary 
circulation is effectively arranged in parallel with the bulk of the cortical circulation,19 and 
that there is likely some level of differential control of perfusion of the inner and outer 
medulla. So to understand the control of oxygen delivery to the medulla we must 
understand the interactions between three sets of nested parallel circulations (Figure 1).  
Our understanding of the control of local renal tissue oxygen consumption is complicated by 
the fact that it is so heavily dependent upon tubular sodium reabsorption.20 Renal oxygen 
consumption (VO2) can be approximated using the formula: =	 +	 = 	 +	   
where VO2basal represents an assumed fixed rate of oxygen consumption required for 
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conditions20), and VO2Na+ represents oxygen utilisation for the reabsorption of sodium. 
VO2Na+, in turn, is dependent both on the molar quantity of sodium reabsorbed and the 
energetic cost of reabsorption of each mole of sodium (β). This formula can be applied both 
across the whole kidney and at the local level. Given that the effects of vasoactive agents on 
local medullary tissue oxygenation cannot always be predicted based on their effects on 
local tissue perfusion and whole-kidney oxygen delivery and consumption,21 local oxygen 
consumption probably plays a critical role in determining local tissue oxygen tension. 
Unfortunately, despite valiant attempts,22 there are no available methods for quantifying 
renal oxygen consumption at the local tissue level in vivo. This represents a significant 
impediment in our understanding of renal oxygenation, since the value of β varies across 
the various segments of the nephron,23 is highly dependent on the neuro-hormonal milieu 
and particularly the bioavailability of nitric oxide,24 and likely changes markedly in the 
diseased25 or injured26 kidney. Furthermore, the quantity of sodium reabsorbed within each 
tubular segments varies with physiological state.23  Given this uncertainty, we see an 
important role for computational models to provide a method for systematic data 
integration, a tool for evaluating ‘what-if’ scenarios, and so a translational pathway between 
basic research findings and improved clinical practice. 
The power of computational modelling is that, by repeating the process of model calibration 
and validation, a model can cumulatively integrate data from all available experiments. This 
gives researchers a systematic method for taking into account all the available quantitative 
and qualitative anatomic and physiological data available, past and present, and putting this 
to work in the service of addressing the research question of interest. By nesting models 
within models, multiscale computational model can integrate data over a range of length 
scales, from cells up to tissues and organ systems. This approach is like a lever on 
experimental data, allowing re-assessment and reinterpretation of data, and suggesting new 
hypotheses as new predictions are made. 
One example of this approach is our recently published papers on accounting for oxygen in 
the rat renal cortex.27, 28 This model drew on detailed geometrical data that were gathered 
with a specific purpose in mind; to assess the importance of renal arterial-to-venous oxygen 
shunting. However, by integrating these new data in the context of data from another 20+ 
prior papers on renal anatomy and physiology in the rat, we were able to reveal a critical 
role for variations in the density of peritubular capillaries in determining renal tissue 
oxygenation (Figure 2). This may at least partly underlie the increased susceptibility of 
patients with CKD, a condition associated with capillary rarefaction, to development of AKI 
under conditions like CPB, when there may be mis-matched changes in renal oxygen 
delivery and oxygen consumption.27  
Evidence that medullary hypoxia is a common pathway in AKI of multiple aetiologies 
Here, we will begin to build the case that because renal medulla hypoxia is a common 











This article is protected by copyright. All rights reserved. 
restating the argument linking AKI to hypoxia. 
The renal medulla is susceptible to hypoxia: Despite the fact that the kidneys receive a 
quarter of the cardiac output, they are susceptible to hypoxia.29 Multiple factors render the 
medulla particularly susceptible to hypoxia, including relatively low blood flow,18 limitations 
in oxygen diffusion due to the relatively low capillary density in the kidney27 and diffusive 
oxygen shunting in the renal cortex (from arteries to veins)28, 30 and medulla itself (from 
descending to long ascending vasa recta).30, 31 Furthermore, the outer medulla contains the 
thick ascending limbs of Henle’s loop (mTALs), which reabsorb much of the filtered sodium, 
and so require a large amount of oxygen. Yet the mTALs are located at the periphery of the 
vascular bundles so have a comparatively meagre oxygen supply.32 It is not surprising then, 
that in human AKI, tubular damage is most often seen in the outer medulla.33 
Medullary hypoxia is common to animal models of AKI, including radiocontrast-induced 
nephropathy, ischaemia reperfusion injury, sepsis, and rhabdomyolysis.18 Medullary hypoxia 
has even been observed in a clinically relevant ovine model of septic AKI in which global 
renal blood flow (RBF) and oxygen delivery are increased and renal cortical oxygenation is 
well maintained.34 It is apparent that medullary hypoxia is not just a consequence of global 
renal ischaemia, but a specific event common to all forms of AKI where it has been 
investigated.  
Tissue hypoxia drives pathology: Depletion of cellular ATP initiates signalling cascades 
leading to inflammation, apoptosis and necrosis.35 Multiple downstream pathways then 
exacerbate tissue hypoxia. For example, oxidative stress and loss of Na,K-ATPase polarity 
and tight junctions between tubular cells reduces the efficiency of oxygen use, which 
increases oxygen consumption. Cellular protective mechanisms, driven by hypoxia inducible 
factors, protect the kidney when hypoxia is mild and/or brief, but fail when hypoxia is 
severe and/or protracted.35 Hypoxia may also contribute to the progression from AKI to 
CKD.36 For example, capillary rarefaction appears to be an early37 and persistent38 event 
after AKI , and is common to all forms of CKD.39, 40 
Medullary hypoxia should reduce glomerular filtration rate: Unfortunately, the mechanistic 
links between tissue hypoxia and glomerular filtration rate have proved difficult to study. 
But from a theoretical perspective, we should expect that, as metabolism switches from 
aerobic to anaerobic, sodium reabsorption in the mTALs should be inhibited. This is 
predicted to activate the tubuloglomerular feedback (TGF) mechanism, causing afferent 
arteriolar vasoconstriction, reducing glomerular filtration and further reducing oxygen 
delivery to the medulla. Hypo-filtration might be exacerbated by oxidative stress and 
reduced nitric oxide bioavailability and hypoxic damage to tubular and vascular elements in 
the medulla.41 Evidence that TGF is linked to renal oxygenation includes the observation of 
oscillations in glomerular capillary and tubular PO2 that are dependent on TGF.42 
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remain a major gap in our knowledge of the pathophysiological significance of hypoxia in 
AKI. 
Evidence of renal ischaemia and hypoxia during and after cardiopulmonary bypass    
During CPB, perfusionists monitor mixed venous saturation of haemoglobin with oxygen 
(SvO2) and maintain it at 70-80%. This level of venous oxygenation is most commonly 
somewhat greater than that which would be experienced by a resting conscious human (65-
75%), so should theoretically be adequate for oxygenation of all organs. However, one must 
also consider that the local circulations of the various organ systems are in parallel (Figure 
1). Thus, what is adequate for some organs may not be adequate for others. During CPB the 
brain43 and kidney44 appear to be particularly susceptible to ischaemia and hypoxia, and 
thus subsequent damage and dysfunction. 
Multiple factors associated with CPB would be predicted, purely on our understanding of 
circulatory physiology, to promote renal hypoxia. Haemodilution, a necessary consequence 
of priming the CPB circuit, blunts autoregulation of RBF.45 Periods of low pump flow and/or 
arterial pressure would therefore be expected to result in renal ischaemia. Haemodilution 
also reduces the oxygen-carrying capacity of blood and therefore the quantity of renal 
oxygen delivery for any given level of RBF. Haemolysis and associated inflammation and 
oxidative stress would be expected to lead to renal vasoconstriction, as would activation of 
the sympathetic and renin-angiotensin systems. Loss of pulsatility of flow might also be 
expected to promote renal ischaemia.46 
Known intraoperative risk factors for AKI after CPB would be expected to lead to renal 
hypoxia. These include excessive haemodilution47 or relatively low pump flow leading to low 
whole body oxygen delivery,48, 49 and low nadir arterial pressure during CPB.50 All of these 
would be expected to reduce renal oxygen delivery. Many pre-operative risk factors are also 
likely to be associated with reduced oxygen delivery or increased oxygen consumption in 
the kidney, including chronic obstructive pulmonary disease, CKD, infection and 
inflammation, and diabetes.18 Unfortunately, we have virtually no hard evidence regarding 
the influences of these various factors on RBF during CPB. 
We are aware of only two studies in which RBF was estimated during CPB in humans, in 
both cases by measurement of the clearance of para-aminohippurate. Andersson and 
colleagues found that RBF was highly dependent on both pump flow and arterial pressure 
during hypothermic (28 ⁰C) CPB.51 They found that RBF was relatively normal at a high 
pump flow of 2.0-2.2 L min-1m2  but was reduced by ~40% when pump flow was reduced to 
a level considered adequate for such hypothermic conditions (1.45-1.65 L min-1m2; note that 
pump flow is usually calculated as a function of body surface area; i.e. equivalent to the 
‘cardiac index’). Critically, they observed a complete absence of autoregulation of RBF. 
More recently, Lannemyr and colleagues found relatively well-maintained effective RBF 
during CPB (at 34-35 ⁰C), but some redistribution of whole body blood flow away from the 
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delivery was well-maintained on CPB, renal oxygen delivery was still reduced by ~20%.52    
Even if whole-kidney oxygen delivery is maintained during CPB, there is the potential for 
altered distribution of blood flow, via microvascular shunting, to induce renal tissue hypoxia 
by reducing tissue oxygen extraction. Koning and colleagues observed increased 
heterogeneity of flow in the sublingual circulation of patients during on-pump 
cardiothoracic surgery, but not during off-pump cardiothoracic surgery.53 The existence of 
peri-glomerular shunt pathways in the renal circulation has long been a controversial 
proposition.54 Nevertheless, it is noteworthy that Pathi and colleagues observed reduced 
renal vascular resistance in pigs during CPB (albeit measured by the flawed microsphere 
method), associated with reductions in glomerular size because of glomerular capillary 
narrowing.55 These observations could indicate shunting of RBF away from glomerular 
capillaries during CPB. A similar mechanism has been proposed as a possible explanation for 
failure of glomerular filtration in hyperdynamic sepsis.56  
Computational models predict the development of renal medullary hypoxia during CPB. 
Sgouralis and colleagues simulated hypothermic (28 ⁰C) CPB using models of the kidney of 
the rat.57, 58 Their findings indicate that the rewarming phase of CPB, prior to weaning from 
CPB, is a time of greatest risk of medullary hypoxia (Figure 3). Their models predict PO2 in 
the vicinity of the mTALH to be less than 5 mmHg during re-warming, as a result of the 
increased metabolic activity and thus oxygen consumption caused by increased tissue 
temperature. These predictions accord with the clinical observation that rewarming on 
bypass increases the risk of AKI.59 Excessive cooling also appears to promote AKI, since 
arterial perfusion temperature <27 ⁰C during CPB was found to be associated with increased 
risk of AKI.60 Thus, it may be that the rate of re-warming, rather than the perfusion 
temperature during hypothermic CPB, is a critical factor in determining risk of AKI. The 
impact of re-warming regimens on renal haemodynamics and oxygenation has not, to our 
knowledge, been systematically investigated in experimental animals or man. 
Renal tissue PO2 has been directly measured in experimental animals during CPB. In pigs, 
medullary and urinary hypoxia (PO2 1-5 mmHg for both) were observed during CPB.61 In 
rats, CPB was associated with transient cortical and medullary hypoxia at a target blood 
haemoglobin concentration of 10 g/dL, but sustained hypoxia in both regions of the kidney 
when target haemoglobin was 6.5 g/dL.62 Thus, evidence from experimental animals 
strongly supports the proposition that CPB is associated with intra-operative renal hypoxia 
that is exacerbated by anaemia.  
Renal hypoxia also appears to be a hallmark of AKI after CPB.26 In patients with AKI after CPB 
both renal blood flow measured by para-amonohippurate clearance (-40%) and renal 
oxygen delivery (-62%) were found to be markedly reduced 63. In contrast, renal oxygen 
consumption was found to be maintained, despite reduced glomerular filtration rate (GFR) 
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efficiency of oxygen utilisation for sodium reabsorption is reduced in AKI. In pigs, medullary 
hypoxia was observed 24 h after CPB.64-66 Furthermore, therapies instituted during CPB, that 
ameliorated post-CPB renal dysfunction, also ameliorated post-CPB medullary hypoxia. 
These included blockade of endothelin type A receptors,65 inhibition of phosphodiesterase-
5,66 and reversal of intra-operative anaemia.64 Thus, it appears likely that amelioration of 
post-CPB renal hypoxia can reduce the risk of renal dysfunction. A method to monitor 
intrarenal oxygenation intra-operatively may therefore provide a useful tool to manage the 
risk of AKI in patients during cardiac surgery.  
How could we detect intraoperative renal hypoxia? 
A measure of renal oxygenation during the operation could give a real-time assessment of 
risk of AKI and potentially justify and enable interventions during surgery (i.e. prior to 
injury). Unfortunately, it is not currently feasible to directly measure the oxygen tension 
(PO2) of renal tissue during cardiothoracic surgery. However, there have been indirect 
measurements. Choi and colleagues used near infrared spectroscopy to assess the regional 
saturation of intrarenal (and cerebral) haemoglobin with oxygen (rSO2) in 95 adult patients 
during cardiac surgery with CPB.67 They found that both renal and cerebral rSO2 fell at the 
commencement of CPB. Renal rSO2 recovered during the initial stages of CPB but then 
slowly decreased. They also found that patients who developed AKI experienced longer 
periods during surgery during which saturation of intrarenal haemoglobin with oxygen was 
below thresholds of 70%, 65%, 60%, 55% and 50%. Furthermore, the odds of post-operative 
AKI were significantly greater as patients experienced more severe and longer periods of 
desaturation of renal haemoglobin. Similarly, infants who developed AKI after cardiac 
surgery on CPB experienced more severe intraoperative desaturation of renal tissue than 
those who did not develop AKI.68 Thus, intra-operative monitoring of renal oxygenation 
could potentially be used to assess the risk of AKI at a time when it might not be too late to 
intervene to prevent kidney injury. Unfortunately, near infrared spectroscopy may not be an 
ideal method for this purpose, since it could not be applied in adult patients whose kidneys 
were more than 40 mm below the surface of the skin67 or in paediatric patients older than 
12 months or weighing more than 10 kg.68   
We have recently proposed that continuous measurement of urinary PO2 could be used to 
estimate renal medullary tissue PO2, and thus could be used as a ‘physiological biomarker’ 
of risk of AKI.69, 70 Our argument was based on the observations that (i) the ascending vasa 
recta are closely associated with collecting ducts in the medulla so that pelvic urinary PO2 
equilibrates with medullary tissue PO2 and (ii) the PO2 of urine in both the renal pelvis and 
the bladder varies in response to stimuli that would be expected to alter medullary tissue 
PO2. More recently, we developed a computational model of oxygen diffusion across the 
urothelium of the ureter which predicts good agreement between medullary and bladder 
urinary PO2, provided that urine flow is adequate (Figure 4).71 Consistent with this 
proposition, we found good agreement between medullary tissue PO2 and bladder urinary 
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oxygenation was altered pharmacologically.71  
Kainuma and colleagues measured bladder urine PO2 during on-pump cardiac surgery in 98 
patients, using a polarographic electrode inserted into the bladder catheter.73 They found 
that urinary PO2 fell during CPB and that failure of urinary PO2 to increase/recover after CPB 
predicted later development of AKI. However, because polarographic electrodes are fragile 
and require repeated calibration, their approach is unlikely to be feasible in routine clinical 
practice. However, recent fibre optic methods for PO2 measurement by luminescence 
lifetime oximetry, could provide a clinically translatable method.69, 70 
 
Potential interventions to improve renal oxygenation during cardiopulmonary bypass 
Off-pump surgery 
One potential solution to avoid CPB-associated renal hypoxia is to avoid CPB altogether. Off-
pump cardiac surgery has been found to be associated with a lower risk of AKI than cardiac 
surgery on CPB.74, 75 However, in a recent multicentre trial the investigators could detect no 
benefit of off-pump surgery in terms of loss of kidney function at 1 year.74 Thus, significant 
benefits of off-pump surgery for the kidney have not been demonstrated. This apparent lack 
of benefit could be due to the common occurrence of haemodynamic instability during off-
pump procedures.76 There is also evidence of poorer outcomes in terms of completeness of 
revascularization during the surgical procedure and graft patency one year after coronary 
artery bypass graft,77 and the need for repeat revascularization.75 
 
Anaemia and transfusion 
The established relationship between intra-operative anaemia and post-operative AKI (vide 
supra) provided the impetus for studies of the effects of correction of anaemia by blood 
transfusion. Available evidence from observational studies indicates that early transfusion 
to correct anaemia may exacerbate, rather than ameliorate, the risk of AKI.78 Transfusion of 
more than two units of packed red blood cells was also found to be associated with 
increased levels of the urinary biomarkers interleukin-18 and neutrophil gelatinase-
associated lipocalin.79 A potential explanation for this apparent paradox is that stored red 
blood cells have reduced affinity for oxygen, are less deformable, have shorter lifespans 
compared with the patient’s own red blood cells, and are prone to damage and thus 
liberation of free haemoglobin.78, 80 However, the absence of well-designed randomised 
trials in this field remains a significant impediment to our understanding of the effects of 
blood transfusion. The results of an ongoing randomised trial comparing a restrictive versus 
a liberal transfusion strategy may clarify this issue (Transfusion Requirements in Cardiac 
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Cooling and rewarming on bypass 
Simulations using computational models indicate that cooling on bypass reduces renal 
oxygen consumption and so protects the renal medulla from hypoxia, but that rewarming 
on bypass promotes renal medullary hypoxia (Figure 3).57, 58 Rewarming on bypass per se,59 
hyperthermic perfusion (arterial outlet temperature >37 ⁰C),81, 82 and higher ICU admission 
temperature81 have been shown to be associated with increased risk of post-operative AKI. 
However, neither sustained intra-operative mild hypothermia (34 ⁰C versus 37 ⁰C)59 nor 
sustained moderate hypothermia (28-30 ⁰C versus 35.5-36.5 ⁰C)83 were found to be 
associated with reduced incidence of AKI after coronary artery bypass graft. Furthermore, a 
recent meta-analysis failed to detect a beneficial effect of therapeutic hypothermia on the 
incidence of AKI after CPB or in other settings (e.g. after cardiac arrest).84 The lack of 
apparent benefit of therapeutic hypothermia on post-operative renal function after CPB 
may reflect both the eventual need for rewarming and the well-established effect of 
hypothermic perfusion to increase renal vascular resistance.85  
 
Management of pump flow and arterial pressure on bypass 
Another approach to prevention of renal hypoxia during CPB could be to optimise 
haemodynamic conditions during perfusion (i.e. pump flow and arterial pressure) to 
maintain kidney oxygenation. Remarkably, this approach has been little-studied. There are 
at least three factors that complicate our ability to tailor perfusion conditions to optimize 
kidney oxygenation. Firstly, we must consider that the kidneys are arranged in parallel with 
other organs in the systemic circulation (Figure 1). Consequently, perfusion conditions that 
are adequate for some organs may not be adequate for the kidney (and vice versa). 
Secondly, we must consider that the renal medullary circulation is arranged in parallel with 
the bulk of the renal cortex (excluding the juxtamedullary cortex)19 and the potential for 
redistribution of blood flow between the inner and outer medulla (Figure 1). Thus, perfusion 
conditions that are adequate for the renal cortex may not be adequate for the renal medulla 
(and vice versa). Thirdly, we must consider that tissue oxygenation is determined by the 
balance between local oxygen delivery and oxygen consumption. Below, we consider the 
evidence from clinical studies that perfusion conditions influence post-operative renal 
function, before considering the experimental evidence that manipulation of perfusion 
conditions might alter renal perfusion and oxygenation. 
 
Clinical observations: Intuitively, one would expect that maintenance of both a relatively 
high pump flow and high MAP during CPB would optimise renal perfusion and oxygenation, 
and thus mitigate the risk of AKI. There is strong evidence that low pump flow on CPB 
increases the risk of AKI.86, 87 However, the impact of arterial pressure during CPB on post-
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failed to detect a relationship between MAP on CPB and post-operative renal function.88-90 
Furthermore, we are unaware of any prospective trials that have demonstrated a clear 
effect of CPB perfusion pressure on post-operative renal function. For example, Urzua and 
colleagues failed to detect differences in post-operative outcomes in small samples of 
patients in whom arterial pressure was maintained above 70 mmHg by infusion of 
noradrenaline (n = 7) compared with another group (n = 14) whose arterial pressure during 
CPB was 10-15 mmHg lower.91 Creatinine clearance was greater during CPB, but not post-
operatively, in the groups of patients with higher arterial pressure. Similarly, Sirvinskas and 
colleagues could not detect a relationship between MAP during CPB and post-operative 
serum creatinine in 122 elderly patients randomised to target levels of MAP of 45.0-59.9 
mmHg, 60.0-69.9 mmHg or 70-95 mmHg.92 
 
On the other hand, it may be that periods of intra-operative hypotension, and/or a failure to 
match MAP on bypass with pre-operative MAP, increase the risk of AKI, and might not be 
captured in studies in which MAP is averaged over the total period of CPB. For example, 
Fischer and colleagues, in a retrospective analysis, also could not detect a relationship 
between post-operative renal function and average MAP on CPB.86 However, they did find 
that patients who developed post-operative acute renal failure (i.e. requiring 
hemofiltration/dialysis) or mild renal impairment experienced longer periods at MAP below 
60 mmHg, and lower mean pump flow on CPB, than those who did not. Haase and 
colleagues were unable to reproduce this finding in a larger retrospective study of 920 
patients.90 However, they did identify a trend for intra-operative hypotension to exacerbate 
the increased risk of AKI associated with intra-operative anaemia. Furthermore, Kanji and 
colleagues found that the magnitude of the difference between pre-operative MAP and 
MAP on CPB was independently associated with risk of post-operative AKI in a group of 157 
high-risk patients.87 Thus, it remains possible that better management of MAP on bypass, 
including avoidance of periods of hypotension, particularly in anaemic patients, and better 
matching of MAP on bypass to the patient’s normal resting level of arterial pressure, could 
mitigate the risk of AKI.  
 
Both low haematocrit and low pump flow during CPB are predictors of AKI, but they are also 
the two major determinants of whole body oxygen delivery, an independent predictor of 
AKI.48, 93 This has led to the suggestion that AKI might be avoided in patients with anaemia 
by increasing pump flow.94 However, we are not aware of any interventional studies to 
directly test this hypothesis. Ranucci and colleagues also identified a critical value of whole 
body oxygen delivery, below which hyperlactaemia is more likely to develop (260 ml min-1m-
2). We note that these data relate to systemic lactate and whole body oxygen delivery.94 
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arterio-venous lactate gradient might be useful for optimising pump flow for management 
of kidney oxygenation.  
It is clear from the preceding discussion that optimisation of intrarenal oxygenation, and 
thus potentially the risk of AKI, requires a more evidence-based approach. What, then, can 
we glean from the available experimental observations?  
Experimental observations: Mackay and colleagues assessed regional perfusion using 
microspheres in pigs during normothermic CPB.95 They found that increasing pump flow, 
and thus perfusion pressure from 45 to 90 mmHg, increased renal and splanchnic perfusion 
but not cerebral perfusion. In another study, this group showed that increasing MAP by 
increasing pump flow was markedly more effective at increasing global RBF than was 
infusion of phenylephrine to achieve an equivalent MAP at a lower pump flow.96 
Remarkably, they were unable to detect autoregulation of RBF in either study. These 
experimental observations accord with the only available clinical observations of the effects 
of altered pump flow on RBF in human patients, showing a virtually linear relationship 
between RBF and both pump flow and MAP.51 Thus, although it may be feasible and safe to 
manipulate MAP pharmacologically without altering pump flow,97 it seems unlikely that RBF 
can be improved without some level of increased pump flow.  
 
We are not aware of any studies in which the effects of altered MAP, induced by alterations 
in pump flow and/or vasopressor support, have been systematically investigated with the aim 
of determining their relative effects on RBF or local renal tissue perfusion and oxygenation. 
The choice of vasoactive agents and their doses, that could potentially be used to optimise 
renal tissue oxygenation, must be based on evidence from clinically relevant large-animal 
models. To this end, Calzavacca and colleagues recently assessed the effects of a range of 
vasoconstrictor factors on regional kidney perfusion and oxygenation in conscious sheep.21 
Rather surprisingly, they found that the effects of noradrenaline, angiotensin II and arginine 
vasopressin on renal cortical and medullary oxygenation could not be predicted based on 
their effects on total RBF, global renal oxygen delivery and renal oxygen consumption, or 
even regional perfusion as assessed by laser Doppler flowmetry. For example, even though 
noradrenaline had little effect on total RBF in this healthy ovine model, it greatly reduced 
both cortical and medullary tissue PO2. In contrast, cortical and medullary tissue PO2 was 
relatively well-maintained during infusion of arginine vasopressin, even though it markedly 
reduced global renal blood flow. These observations are consistent with the concept that 
regional kidney oxygenation is determined by the complex interplay between local tissue 
perfusion (and thus oxygen delivery to tissue) and local tubular sodium reabsorption (and 
thus tissue oxygen consumption).18 They also provide a strong rationale for studies of the 
effects of vasoactive agents on regional kidney oxygenation and perfusion in a clinically 
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studies. Thus, we must conclude that we currently have virtually no directly relevant 
information to inform management of local renal tissue oxygenation through optimization 
of systemic haemodynamics during CPB. 
 
Pulsatile versus non-pulsatile flow 
CPB most often employs non-pulsatile flow. Available perfusion pump technology can at 
least partially restore pulsatility towards that achieved by the heart. The relative merits of 
partial pulsatile versus non-pulsatile flow remain controversial. The increased shear-stress 
and ‘haemodynamic energy’98 associated with partial pulsatile flow should theoretically aid 
tissue perfusion. In humans, partial pulsatile flow on CPB has been demonstrated to 
improve post-operative perfused vessel density in the sublingual circulation99 and improve 
cerebral oxygenation in paediatric patients during CPB.100 In experimental studies, partial 
pulsatile flow has also been shown to improve cerebral blood flow during CPB.101 However, 
effects on RBF and regional kidney perfusion have been variable. Nakamura and colleagues 
demonstrated renal tissue perfusion (as assessed by coloured microspheres) improved more 
during partial pulsatile than non-pulsatile flow in sheep.102 Similar observations were made 
in pigs by Undar and colleagues.101 In contrast, in other experimental studies increased RBF 
during partial pulsatile CPB has either not been observed103, 104 or been of marginal 
significance.105 It has been argued that the continuing controversy regarding the 
effectiveness of partial pulsatile flow is a product of the diversity of equipment deployed to 
achieve pulsatility and its ability to simulate physiological patterns of pulsation.46 Others 
have argued that this is not the case, and that the potential benefits of pulsatility are likely 
blunted by the accompanying greater haemolysis and capillary leak.104 Clearly, more 
systematic efforts are required to resolve this long-standing controversy.  
 
Potential interventions to ameliorate the consequences of renal hypoxia during 
cardiopulmonary bypass 
If renal hypoxia cannot be avoided during CPB, perhaps we can find ways to ameliorate its 
consequences by prophylactic therapies? There has been great recent interest in the 
potential for remote ischaemic preconditioning (RIPC) to protect the heart and other organs 
during CPB. In a multi-centre clinical trial of 240 patients undergoing on-pump cardiac 
surgery, Zarbock and colleagues found that the simple manoeuvre of 3 cycles of 5 min 
ischaemia and 5 min reperfusion in one upper arm after induction of anaesthesia, reduced 
the absolute risk of AKI by 15%.106 However, enthusiasm has been dampened somewhat by 
difficulties in replicating these findings in other studies. Two recent meta-analyses failed to 
find evidence that RIPC reduces the risk of post-operative AKI.107, 108 Thus, if RIPC benefits 
the kidney in cardiac surgery, it might be only under rather specific conditions that remain 
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protective effects of pre-operative activation of hypoxia inducible factors.109 However, no 
therapies have yet been translated into clinical practice.   
There is also scope to tailor interventions in patients with post-operative AKI to optimise 
renal oxygenation.26 Ricksten and colleagues have reported a series of carefully conducted 
clinical studies in which they assessed renal oxygen delivery and renal oxygen consumption 
in patients with and without AKI after cardiac surgery. They showed that patients with AKI 
after cardiac surgery have a deficit in renal oxygen delivery compared to patients without 
AKI, but that renal oxygen consumption is maintained at relatively normal levels, despite 
reduced GFR.63 Thus, AKI after cardiac surgery is associated with increased renal fractional 
oxygen extraction, indicating a worsening of the renal oxygen supply/demand relationship 
in these patients. They have also tested the effects of a number of interventions, commonly 
used to aid resuscitation of the kidney (e.g. to increase GFR), on the renal oxygen 
supply/demand relationship. They found that low-dose vasopressin increased GFR (and thus 
renal oxygen consumption), but reduced RBF (and thus renal oxygen delivery), so increased 
the fractional extraction of oxygen by the kidney.110 In contrast, levosimendan, a drug with 
both positive inotropic and vasodilator effects, increased both RBF and GFR, so had no 
detectable effect on the renal fractional extraction of oxygen.111 Dopamine increased RBF 
without significantly altering GFR, so reduced renal fractional oxygen extraction.112 
Noradrenaline increased both GFR and RBF, while renal oxygen delivery increased but renal 
oxygen extraction did not change significantly, so renal fractional oxygen extraction was 
reduced.113 They also tested the effects of the diuretics mannitol and furosemide in patients 
without AKI after CPB.114 In patients without AKI after cardiac surgery, mannitol increased 
GFR (and thus renal oxygen consumption) without significantly altering RBF (and thus renal 
oxygen delivery). Thus, renal fractional oxygen extraction was increased. Combining an 
infusion of mannitol with furosemide inhibited sodium reabsorption so normalised renal 
fractional oxygen extraction. In patients with AKI, mannitol increased RBF and tended to 
increase GFR, so had no detectable effect on fractional renal oxygen extraction.115 Thus, the 
effects of mannitol, if they exist, appear to be modulated by the presence of AKI. They also 
found, in patients without AKI, that crystalloid (Ringer’s lactate) but not colloid 
(Venofundin®) increased renal fractional oxygen extraction, presumably by increasing 
GFR.116 
Collectively, the observations described in the paragraph above show that therapies aimed 
at improving GFR in patients with post-operative AKI should be administered with caution, 
and with consideration of the likely effects of these treatments on the renal oxygen 
supply/demand relationship. These findings also provide important guidance for intensivists 
with regard to the appropriate choice of therapies to optimise global renal oxygenation. 
However, a note of caution should be added, since their measures of global renal 
oxygenation do not provide information on the relative oxygenation of the renal cortex and 
medulla. Noradrenaline infusion, for example, was found not to worsen the global renal 
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conscious sheep,21 or in conscious sheep with hyperdynamic septic AKI.72 But in both studies 
in sheep, in which it was possible to assess local renal tissue oxygenation, noradrenaline was 
found to induce localized medullary ischaemia and hypoxia. Thus, we really require a 
method to monitor medullary oxygenation in patients with AKI or at risk of developing AKI. 
Our recent studies in experimental animals indicate that continuous measurement of 
urinary PO2 could provide this capability.71, 72, 117      
 
Conclusions and future directions 
The aetiology of AKI after CPB is clearly complex. Nevertheless, there is considerable 
evidence that hypoxia, particularly in the renal medulla, plays some role. We believe at least 
three approaches are required to advance our understanding of this problem. Firstly, we 
require clinically relevant models for the study of renal oxygenation during CPB. Recent 
advances in our ability to monitor regional kidney perfusion and oxygenation in large 
animals make this feasible.118 Secondly, we require methods to monitor renal medullary 
oxygenation in humans during cardiac surgery. Continuous measurement of urinary PO2 
could provide at least a partial solution to this problem.71, 72 Thirdly, we require 
computational models of intrarenal oxygenation applicable to the human condition. 
Unfortunately, currently available models of kidney oxygenation are based exclusively on 
the kidney of the rat,119 but a number of research groups are working towards addressing 
this deficiency. Combining these approaches could provide a translational pathway to 
develop ways to detect renal medullary hypoxia during cardiac surgery and develop rational 
interventions to ameliorate it.  
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Figure Legends 
 
Fig. 1 Schematic of the factors that influence renal oxygen delivery. The renal medullary 
circulation is essentially arranged in parallel with both the extrarenal circulation and the 
cortical vascular bed. Because the resistance to blood flow in the renal circulation before 
the point where the juxtamedullary afferent arterioles branch from cortical radial 
(interlobular) and arcuate arteries is small, the renal circulation can be considered to consist 
of two resistors in parallel, the outer and mid-cortical vascular bed (RC) and the 
juxtamedullary and medullary vascular bed (RM). The resistance of all other vascular beds 
can be lumped together as the extrarenal vascular resistance (RER). Although the relative 
levels of vascular resistance are not directly relevant to consideration of renal oxygenation, 
they have a profound impact on the oxygen delivery to other organs such as the brain and 
splanchnic organs that are also susceptible to damage during cardiopulmonary bypass. 
Other abbreviations: MAP = mean arterial pressure, PRV = renal venous pressure, RBF = renal 
blood flow, RR = renal vascular resistance. Note also that there is the potential for 
redistribution of blood flow between the inner and outer medulla (not shown). 
 
 
Fig. 2 Sensitivity of cortical tissue oxygenation to factors that influence renal oxygen 
delivery and oxygen consumption in a model of oxygen transport in the renal cortex of the 
rat. Relative changes in renal blood flow (RBF), the partial pressure of oxygen in arterial 
blood (PaO2), blood haemoglobin concentration (Hb), glomerular filtration rate (GFR), the 
energetic cost of reabsorption of each mole of sodium (β), and peritubular capillary surface 
area (PCSA), from their physiological base-case, are shown along the x-axis. Simulations 
were run under conditions of low (A; 15,000 mm2), normal (B; 30,000 mm2) and high (C; 
45,000 mm2) PCSA. The numbers within each cell depict the predicted tissue PO2. The cells 
are also colour codes to show the relative change in tissue PO2 from baseline (shown in 
white). Note, in panel B, that of all the variables, tissue PO2 is most sensitive to the effects of 
reducing PCSA. Note also, in panel A, that a deficit in PCSA renders the kidney highly 
susceptible to hypoxia when RBF, PaO2, Hb or β are reduced, or GFR is increased. Figure 
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Fig. 3 Renal medullary tissue and urinary oxygen tension during simulated 
cardiopulmonary bypass in a computational model of the upper urinary tract of the rat. 
Oxygen tension is shown for the interstitial fluid in the inter-bundle region of the lower 
inner stripe of the outer medulla (P , in the vicinity of the thick ascending limbs of the 
loop of Henle; top panel), urine at the outlet of the collecting duct (P , inner 
medulla/renal pelvic urine, middle panel), and in urine in the bladder (P , lower 
panel). The various phases of cardiac surgery are simulated, including the period prior to 
induction of anaesthesia (baseline), after induction of anaesthesia but before commencing 
cardiopulmonary bypass (pre-CPB), during hypothermic (28 ⁰C) CPB, during re-warming on 
CPB (CPB-rewarm) and after weaning from CPB (post-CPB). Three scenarios of are simulated 
with regard to autoregulation of medullary blood flow, ranging from perfect autoregulation, 
to partial (50%) autoregulation, to the complete absence of autoregulation. Note that 
medullary and urinary PO2 are predicted to fall on CPB, particularly during the re-warming 
phase. Note also that the discrepancy between the PO2 of urine in the bladder relative to 
that in the collecting ducts in part reflects the low using flow predicted from this 
computational model.  Figure reproduced, with permission from Oxford University Press on 
behalf of the Institute of Mathematics and its Applications, from Sgouralis et al (2017).58       
 
Fig. 4 Predictions of a computational model of oxygen transport along the rabbit ureter. 
The model generates predictions of pelvic urinary oxygen tension (PO2), and by inference 
the PO2 of the inner medulla, from three input variables: (1) bladder urine PO2, (2) arterial 
blood PO2, and (3) urine flow. Simulations are shown for normoxia (arterial PO2 = 95 mmHg) 
and hyperoxaemic conditions (arterial PO2 = 250 mmHg) such as those that might be 
experienced during major surgery and cardiopulmonary bypass. Figure reproduced, with 
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